Latest filing published 09 Sept 2026 for Bionano Genomics, Inc., €4,169.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Albert Luderer: trading record in brief
All filings by Albert Luderer on record concern Bionano Genomics, Inc. The record holds 2 filings, for trades running from 21 August 2026 to 4 September 2026.
No open-market sale appears; the market trades are 2 purchases worth €8,325. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 9 September 2026: an open-market purchase of €4,169, in Bionano Genomics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Albert Luderer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares@ US$1.2112Common StockSEC:0001746822-26-000005:0Canonical exit: 3 Dec 2026 (T+90)
- 4,000 shares@ US$1.2150.035% mcap100.0% of flowCommon StockSEC:0001746822-26-000003:0Canonical exit: 19 Nov 2026 (T+90)
2 of 2 declarations